Lung Transplant
Conditions
Brief summary
The objective of this Registry is to collect short and long-term post-transplant clinical outcome data of all donor lungs preserved and assessed on the OCS Lung System and to document the performance of the OCS device in the real-world setting after FDA approval in the US.
Interventions
DEVICEOCS Lung
The TransMedics Organ Care System (OCS) Lung is an FDA approved portable extracorporeal lung perfusion and monitoring system.
Sponsors
TransMedics
Study design
Observational model
OTHER
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
All lung transplant recipients
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| One-year patient and graft survival | 1-year post-transplant | Recipients' one-year patient and graft survival rates |
Countries
United States
Contacts
Primary ContactJulia Church
Backup ContactKausar Qidwai
Outcome results
None listed